NSN 6505-01-505-6640, 6505015056640
BUPROPION HYDROCHLORIDE TABLETS

Federal Supply Classification: FSC 6505 - Drugs and Biologicals
National Item Identification Number: NIIN 015056640
Codification Country: United States
Item Name Code: INC 45628
Criticality: (X) This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application.
Hazardous Material Indicator Code: (P) There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product.

Availability: Readily Available Qualified Suppliers: Currently qualifying suppliers

Manufacture or supply this part?
Join our growing community of certified suppliers.

Let Us Know

CALL ABOUT NSN 6505-01-505-6640

Our client representatives are standing by to help fulfill your request.

+1-321-773-5710

REQUEST QUOTE for 6505-01-505-6640

Have a list that needs to be quoted? Upload it here.

Upload a List

DLMS^® Summary

National Stock Number 6505-01-505-6640

National Stock Number (NSN) 6505-01-505-6640, or NIIN 015056640, (bupropion hydrochloride tablets) was assigned March 12, 2003 in the Federal Logistics Information System (FLIS). This NIIN is Available for Manual Assignment. This NSN does not replace any other NSNs.

There are 6 manufacturer part numbers associated with this NSN. None of the associated part number(s) are considered obsolete. The manufacturer part numbers were originally supplied by 3 suppliers. Today, 3 suppliers are listed as Active suppliers for this NSN. Of the active suppliers, 3 suppliers are deemed design controlled or valid supply parts.

This part number has not been procured by the US Government in over a year. There have been 7 contracts issued for this part number, with 7 awards given. There is minimal competition for this NSN. The US Government has awarded contracts to 3 different suppliers. The last contract numbers awarded were: SPE2DP22V1507, SPE2DP22V1507, SPE2DP22V1507, SPE2DP22V1507, SPE2DP22V0667. The total value of the awarded contracts has been US$ 1,438.86.

There has been a small amount of demand for this national stock number. The demand for this NSN originated from less than 5 countries. Based on a planned procurement review by the Primary Inventory Control Activity (PICA) on Dec 02, 2006, this NSN's acquisition method was noted as: Acquire directly from the actual manufacturer, whether or not the prime contractor is the actual manufacturer. This part is a commercial/non-developmental/off-the-shelf-item. Valid AMCs: 1, 2, 3, 4 and 5.

This NSN is assigned to Item Name Code (INC) 45628. []. This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product. NSN 6505015056640 does not contain precious metals.

This information was last updated on Aug 01, 2025.

Technical Characteristics

UNIT PACKAGE TYPE: (PKTY) BOX
SPECIAL FEATURES: (FEAT) GTO HELP WITH A PLAN TO QUIT SMOKING; STORE AT CONTROLLED ROOM TEMP.; DISPENSE IN TIGHT, LIGHT-RESISTANT CONTAINERS; SUSTAINED-RELEASED TABLETS; BOX CONTAINS 1 BOTTLE WITH PATIENT BOOKLET/INSTRUCTIONS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: (CXCY) BUPROPION HYDROCHLORIDE ZYBAN ADVANTAGE PACK BT 150MG 60 TABS INCLUDES PATIENT BOOKLET
ACTIVE MEDICAMENT MEDICINAL STRENGTH: (AKJA) 150.000 MILLIGRAMS BUPROPION HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: (CSGS) ORAL
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: (AJUC) 281604
COATING FEATURE: (BLGJ) FILM, NONENTERIC
LONG ACTION METHOD: (AKJF) EXTENDED RELEASE
PART NAME ASSIGNED BY CONTROLLING AGENCY: (CXCY) BUPROPION HYDROCHLORIDE ZYBAN ADVANTAGE PACK BT 150MG 60 TABS INCLUDES PATIENT BOOKLET
PRIMARY CONTAINER CONTENT QUANTITY: (CRLK) 60.000 TABLETS
PRIMARY CONTAINER TYPE: (CQCT) BOTTLE
SPECIAL FEATURES: (FEAT) TO HELP WITH A PLAN TO QUIT SMOKING; STORE AT CONTROLLED ROOM TEMP.; DISPENSE IN TIGHT, LIGHT-RESISTANT CONTAINERS; SUSTAINED-RELEASED TABLETS; BOX CONTAINS 1 BOTTLE WITH PATIENT BOOKLET/INSTRUCTIONS
SUPPLEMENTARY FEATURES: (SUPP) ADVANTAGE PACK, INCLUDES BT. AND PATIENT BOOKLET
TOTAL PRIMARY CONTAINER QUANTITY: (CSCW) 1
ACTIVE MEDICAMENT MEDICINAL STRENGTH: (AKJA) 150.000 KILOGRAMS PER CUBIC DECIMETER BUPROPION HYDROCHLORIDE CUBIC CENTIMETERS